Clinical utility of HCV core antigen detection and quantification using serum samples and dried blood spots in people who inject drugs in Dar-es-Salaam, Tanzania
Z Mohamed,
J Mbwambo,
Y Shimakawa,
Lila POITEAU,
Stephane CHEVALIEZ,
Jean-Michel PAWLOTSKY,
J Rwegasha,
S Bhagani,
SD Taylor-Robinson,
J Makani,
MR Thursz,
M Lemoine,
j Int AIDS Soc. 19/09/2017;20(1) : 21856 10.7448/IAS.20.1.21856.
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C.
M Buti,
K Agarwal,
Y Horsmans,
W Sievert,
E Janczewska,
S Zeuzem,
L Nyberg,
RS Jr Brown,
Christophe HEZODE,
M Rizzetto,
R Parana,
S De Meyer,
R De Masi,
D Luo,
K Bertelsen,
J Witek,
Gastroenterology 04/09/2017;146(3) : 744-753.e3 10.1053/j.gastro.2013.11.047. 04/09/2017
Elbasvir/Grazoprevir for Patients With Hepatitis C Virus Infection and Inherited Blood Disorders: A Phase III Study.
Christophe HEZODE,
M Colombo,
M Bourliere,
U Spengler,
Z Ben-Ari,
SI Strasser,
WM Lee,
L Morgan,
J Qiu,
P Hwang,
M Robertson,
BY Nguyen,
E Barr,
J Wahl,
B Haber,
R Chase,
R Talwani,
VD Marco
Hepatology. 01/09/2017;66(3) : 736-745 10.1002/hep.29139. 20/07/2017
Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.
Christophe HEZODE,
P Lebray,
V De Ledinghen,
F Zoulim,
V Di Martino,
N Boyer,
D Larrey,
D Botta-Fridlund,
C Silvain,
H Fontaine,
L D'Alteroche,
V Leroy,
M Bourliere,
I Hubert-Fouchard,
D Guyader,
I Rosa,
E Nguyen-Khac,
L Fedchuk,
R Akremi,
Y Bennai,
A Filipovics,
Y Zhao,
JP Bronowicki,
Liver Int. 01/09/2017;37(9) : 1314-1324 10.1111/liv.13383 08/03/2017
Simeprevir and daclatasvir for 12 or 24 weeks in treatment-naïve patients with hepatitis C virus genotype 1b and advanced liver disease.
Christophe HEZODE,
PL Almasio,
S Bourgeois,
P Buggisch,
A Brown,
M Diago,
Y Horsmans,
L Serfaty,
F Szalay,
GB Gaeta,
R Planas,
M Schlag,
I Lonjon-Domanec,
E Omoruyi,
R DeMasi,
S Zeuzem,
Liver Int. 01/09/2017;37(9) : 1304-1313 10.1111/liv.13376 13/03/2017
Hepatitis C virus induces a prediabetic state by directly impairing hepatic glucose metabolism in mice
H Lerat,
MR Imache,
J Polyte,
A Gaudin,
M Mercey,
F Donati,
Camille BAUDESSON,
MR Higgs,
A Picard,
C Magnan,
F Foufelle,
Jean-Michel PAWLOTSKY,
J Biol Chem. 04/08/2017;292(31) : 12860-12873 10.1074/jbc.M117.785030. 30/05/2017
